High-Throughput Fluorescence Polarization Method for Identification of FKBP12 Ligands

Journal of Biomolecular Screening

Volumn 7, Issue 6, 2002, Pages 526-530

  Bollini, S ^a,d   Herbst, J J ^a   Gaughan, G T ^a,b   Verdoorn, T A ^a,b,c   Ditta, J ^a,b,c   Dubowchik, G M ^a   Vinitsky, A ^a,b  

^a Department of Neuroscience ^*  (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c Palatin Technologies Inc   (United States)

^d Palatin Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; HISTIDINE; LIGAND; RECOMBINANT PROTEIN;

ARTICLE; DRUG SCREENING; FLUORESCENCE POLARIZATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

DRUG EVALUATION, PRECLINICAL; FLUORESCENCE POLARIZATION; HISTIDINE; HUMANS; LIGANDS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; TACROLIMUS BINDING PROTEIN 1A;

EID: 0642286481     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087057102238626     Document Type: Article

References (29)

1. Fretz H, Albers MW, Gabt A, Standaert RF, Lane \VS, Burakoff SJ, et al: Rapamycin and FK506 binding proteins (immunophilins). J Am Cliem Soc 1991;113:1409-1411.
2. Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MC, et al: Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 1994;77:513-523.
3. Cameron AM, Steiner JP, Sabatini DM, Kaplin AI, Walensky LD, Snyder SH: Immunophilin FK506 binding protein associated with inositol 1,4,5triphosphate receptor modulates calcium flux. Proc Nail Acad Sci USA 1995;92:1784-1788.
4. Wang T, Donahoe PK, Zervos AS: Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12. Science 1994;265:674-676.
5. Lyons WE, George EB, Dawson TM, Steiner JP: Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC 12 cells and sensory ganglia. Proc Nail Acad Sci USA 1994;91:3191-3195.
6. Steiner JP, Dawson TM, Fotuhi M, Glatt CE, Snowman AM, Cohen N, et al: High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 1992;358:584-587.
7. Lyons WE, Steiner JP, Snyder SH, Dawson TM: Neuronal regeneration enhances the expression of the immunophilin FKBP-12. J Neiuvsci 1995;15:2985-2994.
8. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH: Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Five Natl Acad Sci USA I993;90:980S-9812.
9. Li W, Handschumacher RE: Specific interaction of the cyclophilincyclosporin complex with the B subunit of calcineurin. J Biol Cliem 1993:268:14040-14044.
10. Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J: Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science 1991;252:839-842.
11. Ross DT, Valentine HL, Guo H, Hamilton GS, Huang W, Suzdak PD, et al: Novel neuroimmunophilin ligands for FKBP-12 possess potent neurotrophic activity in the mouse MPTP model of Parkinson's disease. Society for Neuroscie nee 1996:297.14.
12. Steiner JP, Connolly MA, Valentine HI, Hamilton GS, Dawson TM, Hester L, et al: Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nature Med 1997;3:421-428.
13. Gold BG, Storm-Dickerson T, Austin DR, Katoh K: FK506, an immunosuppressent, increases functional recovery and axonal regeneration in the rat following axotomy of the sciatic nerve. Society for Nenroscience 1993:543.18.
14. Gold BG, Zeleny-Pooley M, Wang M-S, Chaturvedi P, Armistead DM: A nonimmunosuppressant FKBP-12 ligand increases ner\'e regeneration. Exp Neural 1997;147:269-278.
15. Kofron JL, Kuzmic P, Kishore V, Colon-Bonilla E, Rich DH: Determination of kinetic constants for peptidyl-prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 1991;30:6127-6134.
16. Fesik SW, Neri P: Multidimensional NMR studies of immunosuppressant/ immunophilin complexes. In Clore G (ed): NMR of Proteins. Boca Raton, FL: CRC, 1993:92-133.
17. Shuker SB, Hajduk PJ, Meadows RP, Fesik SW: Discovering high-affinity ligands for proteins: SAR by NMR. defence 1996;274:1531-1534.
18. Graziani F, Aldegheri L, Terstappen GC: High throughput scintillation proximity assay for the identification of FKBP-12 ligands. J Biomol Screening 1999;4:3-7.
19. Weber G: Rotational Brownian motion and polarization of the fluorescence in solutions. Adv Protein Cliem 1953;8:415. l
20. Dandliker WB, Feigen GA: Quantification of the antigen-antibody reaction by the polarization of fluorescence. Biochem Biophys Res Commun 1961;5:299-304.
21. Dubowchik GM, Ditta JL, Bollini S, Herbst J, Vinitsky A: Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay. Bioorg Med Cliem Lett 2000;20:559-562.
22. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning. Plainview, TX: Cold Spring Harbor Laboratory Press, 1989.
23. Holt DA, Luengo JI, Yamashita DS, Oh HJ, Konialian AL, Yen HK, et al: Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP 12. J Am ChemSoc 1993;115:9925-9938.
24. Munson PJ, Rodbard D: Correction of Cheng Prousoff equation. Journal of Receptor Research 1988;8:533-546.
25. Hamilton GS, Steiner JP: Neuroimmunophilin ligands and novel therapeutics for the treatment of degenerative disorders of the nervous system. Curr Pharin Des 1997;3:405-428.
26. Owicki JC: Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J Biomol Screen 2000;5:297-306.
27. Rajkowski KM, Cittanova N: Corrected equations for the calculation of protein-ligand binding results from fluorescence polarization data. J Theor Biol 1981 ;93:691 -696.
28. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo HZ, Connolly MA, et al: Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Nail Acad Sci USA 1997;94:2019-2024.
29. Bocquet AL, Fuks G, Grimée B, Talaga R, Daliers P, Klitgaard J: Failure of GPI compounds to display neurotrophic activity in vitro and in vivo. Enr J Pharmacol 2001 ;415:173-180.